*Answer: "Easily." * *Because the FDA, like CDC and FCC and all the rest, have no interested whatsoever* *in safeguarding the public health. On the contrary.*
*MCM* How Did Carcinogenic Generic Pill Get Past the FDA?Analysis by Dr. Joseph Mercol <https://www.mercola.com/forms/background.htm>a Sept. 30, 2020 https://articles.mercola.com/sites/articles/archive/2020/09/30/ndma-in-generic-pills.aspx STORY AT-A-GLANCE - Since 2018, the carcinogenic compound NDMA has been found in several different drugs, including three blood pressure medications (valsartan, losartan and irbesartan), two heartburn medications (Zantac and Axid) and the diabetes drug metformin - In the case of valsartan, three companies whose drugs were recalled in 2018 had all purchased the active ingredient from a Chinese manufacturer called Zhejiang Huahai Pharmaceutical Co. - The U.S. Food and Drug Administration checks less than 1% of imported drugs for impurities or potency, and in the past five years have sent warning letters to only 25% of companies suspected of faking quality data - While generics are a boon to patients in that they’re far less expensive while still providing the same benefits, there’s more room for error as they also receive far less scrutiny by regulators, and manufacturers are trusted to regulate themselves - An estimated 80% of all active drug ingredients are manufactured in China and India, and overseas plants are rarely inspected by U.S. authorities --- Support News from Underground: http://bit.ly/NFUSupport You received this email because you are subscribed to News from Underground. To unsubscribe from this email list, please go to: http://www.simplelists.com/confirm.php?u=pIdjNUgiG2h8yxbhC54SSy4SEskAoEMs For archives, please go to: http://archives.simplelists.com/nfu
